Promising new results from psychedelic clinic...

Send us Fan MailIn 2023, the U.S. Surgeon General issued a powerful advisory declaring loneliness and social disconnection a public health crisis. Sometimes called the “loneliness epidemic,” it reflects how—even in a hyperconnected, social media world—many of us feel more isolate ...  Show more

Send us Fan MailIn today’s episode of the Psychedelic Therapy Frontiers podcast we discuss a paper recently published in JAMA (Journal of the American Medical Association) entitled, “Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder: A Randomized Clinical Tr ...  Show more

<span style= "font-size: 10.0pt; mso-bidi-font-family: Arial; mso-bidi-font-style: italic;"> What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributa ...

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more

We’re in the midst of a psychedelic renaissance, where this once demonized class of drugs is now front and center receiving attention among entrepreneurs, investors, clinical trials and even patients. In this special conversation, TED Health’s Dr. Shoshana Ungerleider speaks with ...  Show more

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for de ...  Show more